OCT 25, 2016 8:22 AM PDT

Surprising Gene Mutation Reveals Rare Immunodeficiency

WRITTEN BY: Kara Marker
Next-generation sequencing revealed a rare protein deficiency from an inherited genetic mutation as the cause of a severe immune disease. Until now, the gene’s role in the human immune system was unknown.
The image shows RASGRP1-dependent vesicle transport towards the immunological synapse. Image Credit: CeMM/Tatjana Hirschmugl
One 12-year-old patient is the only affected child in their family, after three of the patient’s siblings died within the first two years of life from a mysterious diseases. Beginning immediately after birth, the patient experienced serious, potentially lethal infections that his immune system couldn’t control. After examination, scientists realized he lacked the lymphocytes for the immune system to successfully mount an attack against infection.

Knowing that three siblings experienced the same disease in addition to the 12-year-old, a collaborative researcher team from CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases and the Medical University at Vienna suggested a heritable genetic trait was the cause of all four conditions. Next-generation genomic sequencing confirmed their theory.

"Our analyses of the patient's and his parents' genomes indeed confirmed that the boy's disorder had a genetic cause," explained the study’s first author, CeMM’s Elisabeth Salzer.

They found that a mutation in the gene encoding a protein called RASGPR1 was at the root of the disease; RASGPR1 is vital in the development of lymphocytes. However, the study also showed that the protein also plays role in the maintenance of the cytoskeleton, the backbone of the cell, in natural killer cells; the details of how the protein affects these lymphocytes is still unknown.

The researchers also showed that, as expected, the healthy parents and healthy siblings had just one copy of the mutation, while the affected 12-year-old had two faulty copies; clearly one mutated copy was not enough to cause the recessive disease.
Senior author Kaan Boztug and first author Elisabeth Salzer. Image Credit: CeMM/Wolfgang Däuble
Until now, RASGPR1’s role in the human immune system was unknown; a mutation that inhibited the protein had never before been reported.

The research team has already made progress in developing treatments for this disease. An FDA-approved drug called lenalidomide has been shown to reverse some of the effects caused by RASGRP1 deficiency. There’s still a long way to go, and scientists are now looking at the possibility of using gene therapy to treat the disease.

This study was recently published in the journal Nature Immunology.
 


Source: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
Stem Cell Derived Natural Killer T Cells as Novel and Long-term Cancer Treatment
Hematopoietic stem cells are used to create a population of Natural Killer T-cells that could sustain and renew within the immune system, and attack cancer cells....
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Effective Vaccines for Lyme Disease?
Currently, there are no effective vaccines available for the presentation of Lyme disease. The only preventive efforts present includes “guiding&rdqu...
OCT 22, 2019
Immunology
OCT 22, 2019
Immune System Responsible for Organ Failure in Malaria
In the most severe cases of malaria, a person can experience organ failure and die. Often times, though, this is not directly due to the parasitic malaria ...
NOV 01, 2019
Immunology
NOV 01, 2019
Immunity to HPV Can Prevent Skin Cancer
Scientists discovered a surprise benefit of low-risk human papillomaviruses (HPV), a typical resident of human skin. New research shows that these harmless...
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
JAN 14, 2020
Technology
JAN 14, 2020
Can Virtual Reality Influence an Increase in Vaccinations?
Can a virtual reality (VR) help increase flu vaccination rates? Apparently, yes! A recent study using VR stimulation is aiming to show how the flu spreads ...
Loading Comments...